Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
The Future of Dermatology: Surviving and Thriving Amid Declining Reimbursement
Description
In a discussion about the future of dermatology amidst declining reimbursements, the speaker outlines the challenges faced due to decreased Medicare payment rates and inflation, which threaten the financial sustainability of dermatology practices. He emphasizes that while demand for dermatological services is high, reimbursement rates often lag significantly behind inflation, making it difficult for practices to survive. The speaker highlights various aspects of billing, encouraging dermatologists to utilize higher-level billing codes (like level four consultations) and specific procedures (such as incisional biopsies) to optimize reimbursements. He warns against relying solely on traditional methods, advocating for using multiple biopsy techniques and maximizing the use of new codes designed to improve compensation for ongoing complex patient care. The discussion also touches on the pitfalls of private equity in dermatology, suggesting their potential benefits could offset some financial burdens by securing better insurance contracts. Finally, the importance of advocacy is reiterated, stressing the need for dermatologists to engage with Congress and encourage patient complaints about access to care, as this could prompt necessary changes in reimbursement practices.
View moreConclusions
- The demand for dermatology services is high, but adequate reimbursement is lacking.
- Current reimbursement rates, particularly from Medicaid and the Affordable Care Act, are unsustainable for dermatology practices.
- Inflation poses a significant threat to independent dermatology practices, with rising costs not matched by increased reimbursement.
- The conversion factor for Medicare payments has decreased sharply from 2001 to 2025, leading to financial struggles.
- The fixed pool of Medicare payment funding hampers the potential for inflation adjustments to reimbursements.
- New coding particularly favors dermatology, providing opportunities to increase billing levels.
- Effective strategies include billing higher level visits, increasing use of incisional biopsies, and consultations to maximize reimbursement.
- Increased patient advocacy directed at Congress can potentially result in better reimbursement conditions for dermatology.
- Private equity has mixed impacts on dermatology practices, with potential benefits in contract negotiation amidst financial struggles.
- American Medical Association
- American Dental Association
- Bureau of Labor Statistics
- Centers for Medicare and Medicaid Services
- Congressional Budget Office
- Federal Register
- Medicare Trustees' Reports